Biochemical Characterization of a Regulatory Cascade Controlling Transcription of the Pseudomonas aeruginosa Type III Secretion System*

Many Gram-negative pathogens utilize type III secretion systems (T3SS) to translocate effector proteins into eukaryotic host cells. Expression of T3SS genes is highly regulated and is often coupled to type III secretory activity. Transcription of the Pseudomonas aeruginosa T3SS genes is coupled to secretion by a cascade of interacting regulatory proteins (ExsA, ExsD, ExsC, and ExsE). ExsA is an activator of type III gene transcription, ExsD binds ExsA to inhibit transcription, ExsC inhibits ExsD activity, and ExsE inhibits ExsC activity. The entire process is coupled to secretion by virtue of the fact that ExsE is a secreted substrate of the T3SS. Changes in the intracellular concentration of ExsE are thought to govern formation of the ExsC-ExsE, ExsC-ExsD, and ExsD-ExsA complexes. Whereas formation of the ExsC-ExsE complex allows ExsD to bind ExsA and transcription of the T3SS is repressed, formation of the ExsC-ExsD complex sequesters ExsD from ExsA and transcription of the T3SS is induced. In this study, we characterized the self-association states of ExsC, ExsD, and ExsE and the binding interactions of ExsC with ExsE and ExsD. ExsC exists as a homodimer and binds one molecule of ExsE substrate. Dimeric ExsC also interacts directly with ExsD to form a heterotetrameric complex. The difference in binding affinities between the ExsC-ExsE (Kd 1 nm) and ExsC-ExsD (Kd 18 nm) complexes supports a model in which ExsC preferentially binds cytoplasmic ExsE, resulting in the inhibition of T3SS gene transcription.

[1]  Evan D. Brutinel,et al.  Characterization of ExsC and ExsD Self-Association and Heterocomplex Formation , 2006, Journal of bacteriology.

[2]  M. Urbanowski,et al.  A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Chia-Fong Wei,et al.  A chaperone‐like HrpG protein acts as a suppressor of HrpV in regulation of the Pseudomonas syringae pv. syringae type III secretion system , 2005, Molecular microbiology.

[4]  P. Sansonetti,et al.  A secreted anti‐activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri , 2005, Molecular microbiology.

[5]  J. Mekalanos,et al.  ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Ghosh Process of Protein Transport by the Type III Secretion System , 2004, Microbiology and Molecular Biology Reviews.

[7]  D. Frank,et al.  ExoU is a potent intracellular phospholipase , 2004, Molecular microbiology.

[8]  M. Wolfgang,et al.  A novel anti‐anti‐activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system , 2004, Molecular microbiology.

[9]  K. A. Walker,et al.  Regulation of the Ysa Type III Secretion System of Yersinia enterocolitica by YsaE/SycB and YsrS/YsrR , 2004, Journal of bacteriology.

[10]  G. Cornelis,et al.  The multitalented type III chaperones: all you can do with 15 kDa. , 2003, FEMS microbiology letters.

[11]  Pradeep K. Singh,et al.  ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon , 2002, Molecular microbiology.

[12]  C. Parsot,et al.  Chaperones of the type III secretion pathway: jacks of all trades , 2002, Molecular microbiology.

[13]  Partho Ghosh,et al.  Three-dimensional secretion signals in chaperone-effector complexes of bacterial pathogens. , 2002, Molecular cell.

[14]  S. Birtalan,et al.  Structure of the Yersinia type III secretory system chaperone SycE , 2001, Nature Structural Biology.

[15]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[16]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[17]  J. Barbieri,et al.  Regulation of ExoS Production and Secretion byPseudomonas aeruginosa in Response to Tissue Culture Conditions , 1999, Infection and Immunity.

[18]  J. Galán,et al.  Identification of a Specific Chaperone for SptP, a Substrate of the Centisome 63 Type III Secretion System ofSalmonella typhimurium , 1998, Journal of bacteriology.

[19]  Dara W. Frank The exoenzyme S regulon of Pseudomonas aeruginosa , 1997, Molecular microbiology.

[20]  B. Iglewski,et al.  Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa , 1991, Journal of bacteriology.

[21]  J. Møller,et al.  Size exclusion chromatography and universal calibration of gel columns. , 1989, Analytical biochemistry.

[22]  J. Sun,et al.  Pseudomonas aeruginosa ExoS and ExoT. , 2004, Reviews of physiology, biochemistry and pharmacology.

[23]  Markus R. Wenk,et al.  Structural and biochemical characterization of the type III secretion chaperones CesT and SigE , 2001, Nature Structural Biology.